Micronuclei formation and aneuploidy induced by Vpr, an accessory gene of human immunodeficiency virus type 1

FASEB Journal

Volumn 13, Issue 6, 1999, Pages 621-637

  Shimura, Mari ^a   Tanaka, Yoshikazu ^b   Nakamura, Satoshi ^a   Minemoto, Yuzuru ^c   Yamashita, Katsumi ^c   Hatake, Kiyohiko ^d   Takaku, Fumimaro ^d   Ishizaka, Yukihito ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Genomic instability; HIV 1 Vpr; Multinucleation

Indexed keywords

CYTOCHALASIN B; DIMETHYL SULFOXIDE; DOXYCYCLINE; MESSENGER RNA; MONOCLONAL ANTIBODY; NOCODAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANEUPLOIDY; ARTICLE; CELL CYCLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MICRONUCLEUS; NONHUMAN; PRIORITY JOURNAL; VIRUS GENOME;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0032919559     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.13.6.621     Document Type: Article

References (71)

1. Cohen, E. A., Dehni, G., Sodroski, J. G., and Haseltine, W. A. (1990) Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J. Virol. 64, 3097-3099
2. Yuan, X., Matsuda, Z., Matsuda, M., Essex, M., and Lee, T.-H. (1990) Human immunodeficiency virus vpr gene encodes a virion-associated protein. AIDS Res. Hum. Retroviruses 6, 1265-1271
3. Paxton, W., Connor, R. I., and Landau, N. R. (1993) Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis. J. Virol. 67, 7229-7237
4. Cohen, É, A., Subbramanian, R. A., and Göttlinger, H. G. (1996) Role of auxiliary proteins in retroviral morphogenesis. Curr. Top. Microbiol. Immunol. 214, 219-235
5. Yu, X.-F., Matsuda, M., Essex, M., and Lee, T.-H. (1990) Open reading frame vpr of simian immunodeficiency virus encodes a virion-associated protein. J. Virol. 64, 5688-5693
6. Hattori, N., Michaels, F., Fargnoli, K., Marcon, L., Gallo, R. C., and Franchini, G. (1990) The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages. Proc. Natl. Acad. Sci. USA 87, 8080-8084
7. Westervelt, P., Henkel, T., Trowbridge, D. B., Orenstein, J., Heuser, J., Gendelman, H. E., and Ratner, L. (1992) Dual regulation of silent and productive infection in monocytes by distinct human immunodeficiency virus type 1 determinants. J. Virol. 66, 3925-3931
8. Emerman, M. (1996) HIV-1, Vpr and the cell cycle. Curr. Biol. 6, 1096-1103
9. Planelles, V., Jowett, J. B. M., Li, Q.-X., Xie, Y., Hahn, B., and Chen, I. S. Y. (1996) Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J. Virol. 70, 2516-2524
10. cdc2 activity. J. Virol. 69, 6705-67
11. Planelles, V., Bachelerie, F., Jowett, J. B. M., Haislip, A., Xie, Y., Banooni, P., Masuda, T., and Chen, I. S. Y. (1995) Fate of the human immunodeficiency virus type 1 provirus in infected cells: a role for vpr. J. Virol. 69, 5883-5889
12. Marzio, P. D., Choe, S., Ebright, M., Knoblauch, R., and Landau, N. R. (1995) Mutational analysis of cell cycle arrest, nuclear localization, and virion packaging of human immunodeficiency virus type 1 Vpr. J. Virol. 69, 7909-7916
13. 2 accumulation by a mechanism which differs from DNA damage checkpoint control. J. Virol. 70, 2324-2331
14. Macreadie, I. G., Thorburn, D. R., Kirby, D. M., Castelli, L. A., de Rozario, N. L., and Azad, A. A. (1997) HIV-1 protein Vpr causes gross mitochondrial dysfunction in the yeast Saccharomyces cerevisiae. FEBS Lett. 410, 145-149
15. Zhang, C., Rasmussen, C., and Chang, L.-J. (1997) Cell cycle inhibitory effects of HIV and SIV Vpr and Vpx in the yeast Schizosaccharomyces pombe. Virology 230, 103-112
16. Bodéus, M., Margottin, F., Durand, H., Rouer, E., and Benarous, R. (1997) Inhibition of prokaryotic cell growth by HIV1 Vpr. Res. Virol. 148, 207-213
17. cdc2-cyclin B. J. Virol. 69, 6859-6864
18. Goh, W. C., Rogel, M. E., Kinsey, C. M., Michael, S. F., Fultz, P. N., Nowak, M. A., Hahn, B. H., and Emerman, M. (1998) HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat. Med. 4, 65-71
19. Lang, S. M., Weeger, M., Stahl-Hennig, C., Coulibaly, C., Hunsmann, G., Müller, J., Müler-Hermelink, H., Fuchs, D., Wachter, H., Daniel, M. M., Desrosiers, R. C., and Fleckenstein, B. (1993) Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J. Virol. 67, 902-912
20. Hartwell, L.H., and Kastan, M.B. (1994) Cell cycle control and cancer. Science 266, 1821-1828
21. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311
22. Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., and Tlsty, T. D. (1992) Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70, 923-935
23. Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., and Wahl, G. M. (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70, 937-948
24. Ishizaka, Y., Chernov, M. V., Burns, C. M., and Stark, G. R. (1995) p53-dependent growth arrest of REF52 cells containing newly amplified DNA. Proc. Natl. Acad. Sci. USA 92, 3224-3228
25. Gualberto, A., Aldape, K., Kozakiewicz, K., and Tlsty, T. D. (1998) An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control. Proc. Natl. Acad. Sci. USA 95, 5166-5171
26. Jin, D.-Y., Spencer, F., and Jeang, K.-T. (1998) Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 93, 81-91
27. Xie, W., Li, L., and Cohen, S. N., (1998) Cell cycle-dependent subcellular localization of the TSG101 protein and mitotic and nuclear abnormalities associated with TSG101 deficiency. Proc. Natl. Acad. Sci. USA 95, 1595-1600
28. Taylor, S. S., and Mckeon, F. (1997) Kinetochore localization of murine Bub1 is required for normal mitotic timing and checkpoint response to spindle damage. Cell 89, 727-735
29. Cahill, D. P., Lengauer C., Yu, J., Riggins, G.J., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., and Vogelstein, B. (1998) Mutations of mitotic checkpoint genes in human cancers. Nature (London) 392, 300-303
30. Beral, V., Peterman, T., Berkelman, R., and Jaffe, H. (1991) AIDS-associated non-Hodgkin lymphoma. Lancet 337, 805-809
31. Biggar, R. J., Rosenberg, P. S., Coté, T., and the Multistate AIDS/Cancer Match Study Group (1996) Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS. Int. J. Cancer 68, 754-758
32. Penn, I. (1978) Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery 83, 492-502
33. Spector, B. D., Perry, G. S., and Kersey, J. H. (1978) Genetically determined immunodeficiency disease (GDID) and malignancy: report from the immunodeficiency cancer registry. Clin. Immunol. Immunopathol. 11, 12-29
34. Lowenthal, D. A., Straus, D. J., Campbell, S. W., Gold, J. W. M., Clarkson, B. D., and Koziner, B. (1988) AIDS-related lymphoid neoplasia. Cancer 61, 2325-2337
35. Mayer, V., Ebbesen, P., and Zachar, V. (1995) Carcinogenic potential of human immunodeficiency virus (HFV): emerging evidence. Eur. J. Cancer Prev. 4, 211-212
36. Laurence, J., and Astrin S. M. (1991) Human immunodeficiency virus induction of malignant transformation in human B lymphocytes. Proc. Natl. Acad. Sci. USA 88, 7635-7639
37. Heddle, J. A. (1973) A rapid in vivo test for chromosomal damage. Mutat. Res. 18, 187-190
38. Schmid, W. (1975) The micronucleus test. Mutat. Res. 31, 9-15
39. Eastmond, D. A., and Tucker, J. D. (1989) Kinetochore localization in micronucleated cytokinesis-blocked Chinese hamster ovary cells: a new and rapid assay for identifying aneuploidy-inducing agents. Mutat. Res. 224, 517-525
40. Eastmond, D. A., and Tucker, J. D. (1989) Identification of aneuploidy-inducing agents using cytokinesis-blocked human lymphocytes and an antikinetochore antibody. Environ. Mol. Mutagen. 13, 34-43
41. Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., and Bujard, H. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769
42. Zhao, L.-J., Mukherjee, S., and Narayan, O. (1994) Biochemical mechanism of HIV-I Vpr function. J. Biol. Chem. 269, 15577-15582
43. Mahalingam, S., Ayyavoo, V., Patel, M., Kieber-Emmons, T., and Weiner, D. B. (1997) Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr. J. Virol. 71, 6339-6347
44. Chen, C., and Okayama, H. (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745-2752
45. Shimura, M., Ishizaka, Y., Yuo, A., Hatake, K., Oshima, M., Sasaki, T., and Takaku, F. (1997) Characterization of room temperature induced apoptosis in HL60. FEBS Lett. 417, 379-384
46. Davis, F. M., Tsao, T. Y., Fowler, S. K., and Rao, P. N. (1983) Monoclonal antibodies to mitotic cells. Proc. Natl. Acad. Sci. USA 80, 2926-2930
47. Yamashita, K., Yasuda, H., Pines, J., Yasumoto, K., Nishitani, H., Ohtsubo, M., Hunter, T., Sugimura, T., and Nishimoto, T. (1990) Okadaic acid, a potent inhibitor of type 1 and type 2A protein phosphatases, activates cdc2/H1 kinase and transiently induces a premature mitosis-like state in BHK21 cells. EMBO J. 9, 4331-4338
48. Benn, P. A., and Perle, M. A. (1992) Chromosome staining and banding. In Human Cytogenetics (Rooney, D. E., and Czepulkpwski, B. H., eds) pp. 91-118, Oxford Press, Oxford, U.K.
49. Withers-Ward, E. S., Jowett, J. B. M., Stewart, S. A., Xie, Y.-M., Garfinkel, A., Shibagaki, Y., Chow, S. A., Shah, N., Hanaoka, F., Sawitz, D. G., Armstrong, R. W., Souza, L. M., and Chen, I. S. Y. (1997) Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair. J. Virol. 71, 9732-9742
50. Ohta, H., Tsurudome, M., Matsumura, H., Koga, Y., Morikawa, S., Kawano, M., Kusugawa, S., Komada, H., Nishio, M., and Ito, Y. (1994) Molecular and biological characterization of fusion regulatory proteins (FRPs): anti-FRP mAbs induced HIV-mediated cell fusion via an integrin system. EMBO J. 13, 2044-2055
51. Ohgimoto, S., Tabata, N., Suga, S., Nishio, M., Ohta, H., Tsurudome, M., Komada, H., Kawano, M., Watanabe, N., and Ito, Y. (1995) Molecular characterization of fusion regulatory protein-1 (FRP-1) that induces multinucleated giant cell formation of monocytes and HIV gp160-mediated cell fusion. FRP-1 and 4F2/CD98 are identical molecules. J. Immunol. 155, 3585-3592
52. Andreassen, P. R., Martineau, S. N., and Margolis, R. L. (1996) Chemical induction of mitotic checkpoint override in mammalian cells results in aneuploidy following a transient tetraploid state. Mutat. Res. 372, 181-194
53. Kimpton, J., and Emerman, M. (1992) Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J. Virol. 66, 2232-2239
54. Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rabson, A., and Martin, M. A. (1986) Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59, 284-291
55. Ohtsuki, T., Hatake, K., Ikeda, M., Tomizuka, H., Terui, Y., Uwai, M., and Miura, Y. (1997). Expression of src-like adapter protein mRNA is induced by all-trans retinoic acid. Biochem. Biophys. Res. Commun. 230, 81-84
56. Levy, D. N., Fernandes, L. S., Williams, W. V., and Weiner, D. B. (1993) Induction of cell differentiation by human immunodeficiency virus 1 vpr. Cell 72, 541-550
57. Ayyavoo, V., Mahboubi, A., Mahalingam, S., Ramalingam, R., Kudchodkar, S., Williams, W. V., Green, D. R., and Weiner, D. B. (1997) HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor κB. Nat. Med. 3, 1117-1123
58. Levy, J. A. (1993) HIV pathogenesis and long-term survival. AIDS 7, 1401-1410
59. Embretson, J., Zupancic, M., Ribas, J. L., Burke, A., Racz, P., Tenner-Racz, K., and Haase, A. T. (1993) Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (London) 362, 359-362
60. Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., and Markowitz, M. (1995) Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 373, 123-126
61. Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., Saag, M. S., and Shaw, G. M. (1995) Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 373, 117-122
62. Levy, D. N., Refaeli, Y., MacGregor, R. R., and Weiner, D. B. (1994) Serum vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 91, 10873-10877
63. Levy, D. N., Refaeli, Y., and Weiner, D. B. (1995) Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. J. Virol. 69, 1243-1252
64. Majone, F., Semmes, O. J., and Jeang, K.-T. (1993) Induction of micronuclei by HTLV-1 Tax:a cellular assay for function. Virology 193, 456-459
65. Semmes, O. J., Majone, F., Cantemir, C., Turchetto, L., Hjelle, B., and Jeang, K.-T. (1996) HTLV-I and HTLV-II Tax: differences in induction of micronuclei in cells and transcriptional activation of viral LTRs. Virology 217, 373-379
66. Li, Y., and Benezra, R. (1996) Identification of a human mitotic checkpoint gene: hsMAD2. Science 274, 246-248
67. Wang, L., Mukherjee, S., Narayan, O., and Zhao, L.-J. (1996) Characterization of a leucine-zipper-like domain in Vpr protein of human immunodeficiency virus type 1. Gene 178, 7-13
68. Macreadie, I. G., Castelli, L. A., Hewish, D. R., Kirkpatrick, A., Ward, A. C., and Azad, A. A. (1995) A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/ F)RIG amino acid motifs causes cell growth arrest and structural defects. Proc. Natl. Acad. Sci. USA 92, 2770-2774
69. Gu, J., Emerman, M., and Sandmeyer, S. (1997) Small heat shock protein suppression of Vpr-induced cytoskeletal defects in budding yeast. Mol Cell. Biol. 17, 4033-4042
70. cdc2 kinase. Nat. Med. 2, 1140-1143
71. Schwartz, D., Almong, N., Peled, A., Gogfinger, N., and Rotter, V. (1997) Role of wild type p53 in the G2 phase: regulation of the gamma-irradiation-induced delay and DNA repair. Oncogene 15, 2597-2607